QoQa Brew, a subsidiary of QoQa Services, has financed its craft brewery through a security token offering. The brewery will be located in the “QG”, a co-working eco-friendly space imagine by QoQa Services, a leading
Tags :Slider
Addex Therapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, has completed a USD 4,2 million equity financing. The allosteric modulation company Addex has entered into a definitive agreement with Armistice Capital, a
German automotive supplier Schaeffler has agreed to acquire Ewellix Group from investment company Triton for approx. EUR 582 million in order to boost its linear range. The invest venture capital company bought the former SKF Motion
Bär & Karrer has represented a former UEFA ethics and disciplinary inspector before the Swiss Federal Supreme Court. In this sense, two former UEFA ethics and disciplinary inspectors have been acquitted in a lawsuit
Ufenau Capital Partners has acquired a majority stake in Dr. Niedermaier Pharma Group, a leading producer and supplier of organic nutritional supplements and natural cosmetics with headquarters in Hohenbrunn near Munich (Germany) and in Appenzell.
Baker McKenzie has acted as legal advisor on the successful offering and listings of Global Depositary Receipts (GDR) on SIX Swiss Exchange of four Chinese companies: GEM Co., Gotion High-tech Co., Keda Industrial Group Co.,
BGPartner has advised in acquisition of tradition Hotel Florhof in Zurich. Silvio Denz, majority shareholder and chairman of Lalique Group, together with entrepreneur Peter Spuhler, have acquired the Hotel Florhof in Zurich, a Zurich hotel
Schellenberg Wittmer has advised Aldo Group International in the successful completion of its Swiss composition proceedings and the exit financing. Aldo Group International is part of the ALDO Group, a Canadian multinational shoe and accessories
Novaremed, a privately held clinical-stage biopharmaceutical company and NeuroFront Therapeutics, a China-based clinical stage neuroscience biotech company, jointly announced the signing of an exclusive collaboration and commercialization agreement for non-opioid investigational drug, NRD.E1. The
JBF Finance has announced a public tender offer for all publicly held shares of SIX listed Bobst Group, the parent company of Bobst, one of the world’s leading suppliers of substrate processing, printing and
